Momentum and Milestones: NewLeaf Aims to Double Sales Next Year

The biological company expands its R&D headquarters and has a lineup of products launches ready for the field, pending regulatory approval.

Root and Stalk Comparison Late Season - Centreville Maryland.jpg
This on-farm trial in Centreville, Maryland compares the grower standard practice to TS201 (right).
(NewLeaf)

With more than 10 years of research and four years of commercial availability, NewLeaf Symbiotics is continuing to chart its own course in bringing row crop and specialty solutions via pink-pigmented facultative methylotrophs (PPFMs).

Its trajectory includes product placement on just under 1 million acres four years ago to having product on more than 8.5 million acres in 2025. Next year’s goal is to double that.

“We’re focused on the next thing, not just the right now,” says Brent Smith, CEO at NewLeaf Symbiotics. “But the right now feels pretty good”

The company recently opened a new formulation office with a larger footprint, advanced laboratories, and strategic location in St. Louis.

“Our success is because we got good at consistency with a tricky microbe class,” Smith says. “The focus is: formulation, optimization and performance. With that we will continue to be consistent.”

The company chose a novel go-to-market in licensing its technologies to partner companies for product placement and sales. Currently, it has a handful of technologies available via 100 commercially available products. The portfolio includes an EPA-registered bioinsecticide and biostimulants for row crops including corn, soybeans, cotton and peanuts, as well as a vegetative transfer biostimulant. Leaders says there’s more to come with launches for 2026, pending regulatory approval.

“We’ve found traction commercially,” says Aaron Kelley, chief commercial officer. “We have three launches in 2026, an EPA-registered biofungicide, nitrogen use efficiency technology, and a specialty biostimulant for transplant vegetables.”

Kelley credits trust built over time for the product growth. He points to the 70% win rate the company boosts as well as a two-year shelf life for its products.

“Every technology that becomes commercially available from NewLeaf has been field tested with multi-year, multi-location, plots of 10+ acres. We want our partners to have confidence in the products they are recommending to their customers.”

Kelley says biologicals can help farmers thread the needle with integrated pest management and layered crop protection.

“It’s been an interesting development to see how people are seeing biologicals as part of integrated pest management,” he says. “And there’s still more to learn and more yield to gain when our technologies are used along with others.”

AgWeb-Logo crop
Related Stories
The collaboration adds Bayer’s formulation, field testing and commercialization to engineered corn microbes that wait for the root, then switch on. CEO Tim Schnabel puts a commercial product around 2029.
With global supply, production costs and geopolitics all in flux, corn and soybean growers face a tough call on how much of their 2027 crop inputs to price this fall.
More yield means more residue, and elevated diesel prices equal a costly fall. Mosaic Biosciences’ new enzyme digester costs about $10 an acre. Application timing decides whether that money buys field operations, emergence/final stand or nutrients.
Read Next
Farmers could see record ARC and PLC payments by the end of October, but estimates of $13.2 to $13.8 billion fall short of early projections, and payment limits could trim individual checks.
Get News Daily
Get Market Alerts
Get News & Markets App